The Brigham’s 7T MRI unit, just the second in the country to be approved for clinical use, revealed that a potential biomarker of brain inflammation in patients affected by multiple sclerosis is more common than previously thought.
The 16-hour surgery, involving a team of over 45 surgeons, nurses, anesthesiologists, residents and research fellows, and led by Bohdan Pomahac, MD, was the ninth face transplant procedure at the Brigham and the 15th nationwide.
A new study suggests positron emission tomography (PET) brain scans could reveal hidden inflammation in patients with multiple sclerosis (MS) who are being treated with highly-effective treatments. Read More...
MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests Read More...
Brigham and Women's Physician Organization, Inc. ("BWPO"), a member of Mass General Brigham Incorporated (MGB) is notifying individuals of an incident it recently became aware of involving some patients' personal information. Read More...
Media Relations, Office of Strategic Communications
(617) 525-6370
Available 24/7: (617) 732-6660
pager #13160